KAP Theory and Methodology | Spring 2022

Faculty

Course Description

Learning Objectives

• Describe the history and theory behind drug-assisted psychotherapy.
• Compare drug-assisted psychotherapy from other psychotherapeutic approaches.
• List the ethical standards of drug-assisted psychotherapy and informed consent shared with patients for clinical trial research and private practice.
• Describe how integration sessions are designed and implemented in clinical trials of psychedelic-assisted therapy.
• List common knowledge gaps patients may have about ketamine-assisted psychotherapy and appropriate knowledge resources.
• Describe the proposed psychological mechanisms of ketamine’s role in psychotherapy.
• Explain ketamine’s proposed mechanisms of action with regard to neuroscience-based narratives.
• Explain how ketamine’s proposed mechanisms of action and neuroscience-based narratives inform clinical processes and practices.
• Demonstrate how to prepare patients to safely receive ketamine-assisted psychotherapy so that they benefit from the experience in ways suitable to their life situation, diagnosis, and intentions.
• Demonstrate how to prepare patients to engage with the experience safely and meaningfully by cultivating attitudes of openness and curiosity toward their experience.
• List a variety of methods to integrate the ketamine experience with patients that align with the practitioner’s existing therapeutic model and the patient’s treatment history.
• Demonstrate a conceptual understanding of the arc of treatment and nonlinear change.
• Describe the wider sociocultural context of drug-assisted psychotherapy, including the stigma and judgment related to drug-assisted psychotherapy that may be experienced by patient and/or practitioner.

Perks

• Registration includes access to our online classroom, course handouts, and private course discussion board. All attendees may opt to be added to our professional community email list of over 800 professionals who have completed this (or similar) courses with us.